Universal Biosensors Inc 's ability to collect accounts receivable sequentially worsen to 3.86, indicating more challenging environment then in the first quarter 2025, but still, it is a far cry from any concerns. Universal Biosensors Inc 's Accounts Receivable average collection period in the Jun 30 2025 quarter, has increased to 95 days, from 79 days, in the Mar 31 2025 quarter.

If we take a look into Healthcare sector 428 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2025 from 2812 to 2825.

What is Receivable Turnover Ratio?
What is Universal Biosensors Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

UBI Receivables Turnover Ratio	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter
Y / Y Receivable Change	18.17 %	74.95 %	20.28 %	13.77 %	104.62 %
Y / Y Revenue Change	-51.2 %	5.79 %	-	-7.12 %	24.69 %
Receivable Turnover Ratio (TTM)	3.86	4.62	5.14	4.41	4.72
UBI's Total Ranking	# 2825	# 2812	# 3011	# 0	# 0
Accounts Receivable average collection period days	95	79	71	83	77
Seq. Receivable Change	-17.44 %	-4.75 %	2.15 %	47.13 %	22.22 %
Seq. Revenue Change	-48.97 %	37.78 %	-36.57 %	9.43 %	10.62 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 155
Healthcare Sector	# 429
Overall Market	# 2825

Receivable Turnover Ratio Statistics
High	Average	Low
0.17	0.1	-0.05
(Mar 31 2025)

UBI Company Profile • Back to UBI Efficiency Comparisons • Compare UBI Receivables Turnover Ratio to its Competitors

Financial Statements
Universal Biosensors Inc 's Accounts Receivable	$ 1 Millions	Visit UBI's Balance sheet
Universal Biosensors Inc 's Sales TTM	$ 5 Millions	Visit UBI's Income Statement
Sources of UBI's Revenues		Visit UBI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
UBI's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
UBI's Growth Rates	UBI's Roa	UBI's Inventory Turnover Ratio	UBI's Dividend Comparisons
UBI's Profitability Ratios	UBI's Roi	UBI's Asset Turnover Ratio	UBI's Dividend Growth
UBI's Valuation Ratios	UBI's Roe	UBI's Financial Strength Ratios	UBI's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2025	Receivable at quarter ending Jun 30 2025
Day One Biopharmaceuticals Inc	12.45	$ 187.638 Millions	$ 15.074 Millions
Rosecliff Acquisition Corp I	12.45	$ 28.320 Millions	$ 2.275 Millions
Chemed Corporation	11.98	$ 2,511.915 Millions	$ 209.599 Millions
Option Care Health Inc	11.97	$ 5,375.352 Millions	$ 449.147 Millions
Corcept Therapeutics Inc	11.93	$ 716.080 Millions	$ 60.020 Millions
Nrc Health	11.89	$ 140.315 Millions	$ 11.805 Millions
Teladoc Health Inc	11.50	$ 2,542.268 Millions	$ 221.147 Millions
Sutro Biopharma Inc	11.35	$ 104.473 Millions	$ 9.208 Millions
Tandem Diabetes Care Inc	11.30	$ 1,001.193 Millions	$ 88.607 Millions
Sanuwave Health Inc	11.30	$ 39.192 Millions	$ 3.470 Millions
Harvard Apparatus Regenerative Technology Inc	11.27	$ 0.679 Millions	$ 0.060 Millions
Integrated Biopharma Inc	11.20	$ 53.562 Millions	$ 4.781 Millions
Lifeloc Technologies Inc	11.00	$ 8.494 Millions	$ 0.772 Millions
Nexgel Inc	10.86	$ 9.518 Millions	$ 0.877 Millions
Immunocore Holdings Plc	10.82	$ 356.145 Millions	$ 32.912 Millions
Ss Innovations International Inc	10.80	$ 32.503 Millions	$ 3.010 Millions
Skinhealth Systems Inc	10.70	$ 309.687 Millions	$ 28.949 Millions
Travere Therapeutics Inc	10.65	$ 333.866 Millions	$ 31.346 Millions
National Healthcare Corp	10.61	$ 1,458.155 Millions	$ 137.376 Millions
Zomedica Corp	10.56	$ 28.979 Millions	$ 2.744 Millions
Strata Critical Medical Inc	10.56	$ 254.341 Millions	$ 24.093 Millions
Biofrontera Inc	10.46	$ 47.521 Millions	$ 4.544 Millions
Ars Pharmaceuticals Inc	10.36	$ 112.339 Millions	$ 10.844 Millions
Addus Homecare Corp	10.31	$ 1,274.240 Millions	$ 123.546 Millions
Sunshine Biopharma Inc	10.30	$ 36.342 Millions	$ 3.530 Millions
Exact Sciences Corporation	10.29	$ 2,950.661 Millions	$ 286.731 Millions
Lftd Partners Inc	10.21	$ 36.620 Millions	$ 3.586 Millions
Sintx Technologies Inc	10.20	$ 1.861 Millions	$ 0.183 Millions
Dyadic International Inc	10.02	$ 4.135 Millions	$ 0.413 Millions
Rockwell Medical inc	10.01	$ 87.415 Millions	$ 8.733 Millions

Date modified: 2026-08-29T17:17:30+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.